CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial By: MarketWatch November 02, 2020 at 10:54 AM EST German biotech CureVac said advanced clinical trials are on track to launch by the end of 2020. Read More >> Related Stocks: Biontech Se ADR Curevac N.V. Gsk Plc ADR Microsoft Moderna Inc Pfizer